Niosomal system can be used as diagnostic
agents. Conjugated niosomal formulation of
gadobenate dimeglcemine with [N-palmitoylglucosamine
(NPG)],
PEG 4400, and both PEG and NPG exhibit
significantly improved tumor targeting of an
encapsulated paramagnetic agent assessed
with MR imaging47.